Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B
Clinical trial NCT02881008 · COMPLETED
Trial details
- NCT number
- NCT02881008
- Sponsor
- Hepatera Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-14
- Primary completion
- 2014-10-04
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.